HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Poppy Seed Tea Latest Catch In FDA Enforcement Net For Opioid Claims

This article was originally published in The Rose Sheet

Executive Summary

PoppySeed Wash ‘medicinal’ beverage claiming to help ease opioid withdrawal and ease pain is an unapproved new drug and is misbranded, FDA says. Agency's warning is latest on supplements making opioid withdrawal claims, but the action has not prompted the Utah firm to discontinue selling its product online.


Related Content

Drug Abuse Withdrawal Supplement Marketers Warned, Claims And Sales Continue
Opioid-Withdrawal 'Aids' Warrant Immediate FDA, FTC Action – CSPI
FDA Turns Kratom's Future In US Dietary Supplement Market Into History





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts